Hematological toxicities in PARP inhibitors: A real‐world study using FDA adverse event reporting system (FAERS) database

OBJECTIVE: Poly ADP‐ribose polymerase inhibitors (PARPis) have significantly improved clinical effects in gynecological oncology. However, PARPis could also induce severe organ system toxicities, including the hematological system. Our study aimed to extensively characterize the hematological toxici...

Descripción completa

Detalles Bibliográficos
Autores principales: Shu, Yamin, Ding, Yufeng, He, Xucheng, Liu, Yanxin, Wu, Pan, Zhang, Qilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939145/
https://www.ncbi.nlm.nih.gov/pubmed/35871395
http://dx.doi.org/10.1002/cam4.5062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939145/
https://www.ncbi.nlm.nih.gov/pubmed/35871395
http://dx.doi.org/10.1002/cam4.5062

Ejemplares similares